AUS
NZ
UK
CA
USA
IND
_06_16_2026_04_54_27_535266.jpg)
Highlights
Several ASX 200 shares recorded significant growth during FY25, with gold miners leading the pack
The surge in gold prices played a key role in lifting four gold-related stocks to new heights
Healthcare and consumer sectors also saw substantial growth with Sigma Healthcare and Temple & Webster featuring prominently
The Australian resources sector, anchored by companies listed on the ASX 200, delivered a strong performance in FY25, aided by a persistent uptrend in gold prices. The precious metal reached new records, propelling several mining shares to substantial gains. A group of gold-related names not only benefitted from strong pricing but also captured the top spots among the market’s highest performers.
Among the leaders were Regis Resources Ltd (ASX:RRL) and Genesis Minerals Ltd (ASX:GMD), both of which maintained strong momentum throughout the financial year. Their growth came amid a favourable macro backdrop that supported sustained interest in commodity-based equities.
Regis Resources and Genesis Minerals Headline Mining Gains
Regis Resources closed the financial year with a markedly higher valuation, having attracted interest from gold market participants and broader commodity-focused trading desks. The company's operations continued to align with the sector-wide tailwinds, positioning it prominently among top movers within the index.
Genesis Minerals, another notable participant in the ASX-listed gold space, also delivered strong gains. The company's performance reflected an industry-wide uplift supported by rising commodity prices and investor sentiment around precious metal stability amid macroeconomic flux.
These performances contributed significantly to the strength observed in the All Ordinaries and ASX 300 indices throughout the year.
Sigma Healthcare Surges Following Strategic Merger News
Outside the mining sector, Sigma Healthcare Ltd (ASX:SIG) stood out following key developments linked to its business transformation. The ASX-listed pharmaceutical distributor gained notable momentum after confirming a merger arrangement involving Chemist Warehouse.
This strategic move contributed to renewed market attention, positioning the company among the top performers across the healthcare segment. The share price reflected optimism around the combined entity’s operational footprint and potential efficiencies, helping to push Sigma ahead of its peers on the ASX 100.
Temple & Webster Marks Breakout Year in Consumer Discretionary
E-commerce retailer Temple & Webster Group Ltd (ASX:TPW) also posted substantial gains in FY25. The company’s strong digital presence and response to shifting consumer trends continued to underpin its growth narrative. With the retail sector navigating evolving spending patterns, Temple & Webster maintained relevance by leveraging online demand.
Its strong showing helped uplift sentiment across the consumer discretionary segment, providing balance to commodity-led movements in the broader market.
These FY25 developments illustrated a broadening of strength across key ASX sectors, reinforcing the dynamic performance observed on the ASX 200 through the year.
